Laboratorios Rovi
Rovi formaliza la adquisición de una planta de fabricación de medicamentos...
710
| Ticker | ROVI |
|---|---|
| ISIN | ES0157261019 |
| Sector | Atención sanitaria |
| Industria | Biotechnology |
| Mercado | Mercado Continuo |
| Capitalización | 4.127.764.489 € |
| Beta | 0,33 |
| Último dividendo | 0,9351 US$ |
| Sitio web | https://www.rovi.es |
| CEO | Juan Lopez-Belmonte Encina |
| Fecha de IPO | 05/12/2007 |
| País | ES |
| Dirección | Calle José Isbert, 2, Madrid, 28223 |
| Volumen | 87.101 |
Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company distributes other products that are licensed from other laboratories. Its principal products include Hibor, a low-molecular-weight heparin to prevent and treat venous thromboembolic disease; Enoxaparin biosimilar Becat, a low-molecular-weight heparin; Neparvis to treat symptomatic chronic heart fa...
Laboratorios Rovi opera en el sector Healthcare, industria Biotechnology.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones